Literature DB >> 19851749

Mitogenic action of insulin: friend, foe or 'frenemy'?

B Draznin1.   

Abstract

Either endogenous or exogenous hyperinsulinaemia in the setting of insulin resistance promotes phosphorylation and activation of farnesyltransferase, a ubiquitous enzyme that farnesylates Ras proteins. Increased availability of farnesylated Ras at the plasma membrane enhances mitogenic responsiveness of cells to various growth factors, thus contributing to progression of cancer and atherosclerosis. This effect is specific to insulin, but is not related to the type of insulin used. The stimulatory effect of hyperinsulinaemia on farnesyltransferase in the presence of insulin resistance represents one potential mechanism responsible for mitogenicity and atherogenicity of insulin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851749     DOI: 10.1007/s00125-009-1558-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.

Authors:  E Stephens; P J Thureen; M L Goalstone; M S Anderson; J W Leitner; W W Hay; B Draznin
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-08       Impact factor: 4.310

Review 2.  Effects of chronic hyperinsulinemia in insulin-resistant patients.

Authors:  Sergio Muntoni; Sandro Muntoni; Boris Draznin
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

3.  Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.

Authors:  M L Goalstone; B Draznin
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

4.  Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.

Authors:  B Draznin; P Miles; Y Kruszynska; J Olefsky; J Friedman; I Golovchenko; R Stjernholm; K Wall; M Reitman; D Accili; R Cooksey; D McClain; M Goalstone
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

Review 5.  Molecular mechanisms of insulin resistance that impact cardiovascular biology.

Authors:  Cecilia C Low Wang; Marc L Goalstone; Boris Draznin
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

6.  Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Authors:  Samantha L Bowker; Sumit R Majumdar; Paul Veugelers; Jeffrey A Johnson
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

7.  Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.

Authors:  M L Goalstone; J W Leitner; K Wall; L Dolgonos; K I Rother; D Accili; B Draznin
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

Review 8.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

9.  Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras.

Authors:  R H Medema; A M de Vries-Smits; G C van der Zon; J A Maassen; J L Bos
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Authors:  Sao Jiralerspong; Shana L Palla; Sharon H Giordano; Funda Meric-Bernstam; Cornelia Liedtke; Chad M Barnett; Limin Hsu; Mien-Chie Hung; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

View more
  16 in total

1.  Mitogenic effect of insulin and developmental programming.

Authors:  F A Van Assche; R Devlieger; T Harder; A Plagemann
Journal:  Diabetologia       Date:  2010-03-12       Impact factor: 10.122

2.  History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.

Authors:  Albina N Minlikeeva; Jo L Freudenheim; Rikki A Cannioto; J Brian Szender; Kevin H Eng; Francesmary Modugno; Roberta B Ness; Michael J LaMonte; Grace Friel; Brahm H Segal; Kunle Odunsi; Paul Mayor; Emese Zsiros; Barbara Schmalfeldt; Rüdiger Klapdor; Thilo Dӧrk; Peter Hillemanns; Linda E Kelemen; Martin Kӧbel; Helen Steed; Anna de Fazio; Susan J Jordan; Christina M Nagle; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Robert Edwards; Keitaro Matsuo; Mika Mizuno; Beth Y Karlan; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Joellen M Schildkraut; Kathryn L Terry; Daniel W Cramer; Elisa V Bandera; Lisa E Paddock; Lambertus A Kiemeney; Leon F Massuger; Jolanta Kupryjanczyk; Andrew Berchuck; Jenny Chang-Claude; Brenda Diergaarde; Penelope M Webb; Kirsten B Moysich
Journal:  Cancer Causes Control       Date:  2017-03-14       Impact factor: 2.506

Review 3.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 4.  Glycemic index, glycemic load, and lung cancer risk: A meta-analysis of cohort and case-control studies.

Authors:  Hongzhen Du; Tianfeng Zhang; Xuning Lu; Meicui Chen; Xiaoling Li; Zengning Li
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

5.  Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

Authors:  Xiang Shu; Lang Wu; Nikhil K Khankari; Xiao-Ou Shu; Thomas J Wang; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Roger L Milne; Marjanka K Schmidt; Paul D P Pharoah; Irene L Andrulis; David J Hunter; Jacques Simard; Douglas F Easton; Wei Zheng
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

6.  Investigating the associations of glycemic load and glycemic index with lung cancer risk in the Southern Community Cohort Study.

Authors:  Xiang Shu; Danxia Yu; Xiao-Ou Shu; Heather M Munro; Wei Zheng; William J Blot
Journal:  Cancer Causes Control       Date:  2020-09-11       Impact factor: 2.506

Review 7.  Rising incidence and challenges of childhood diabetes. A mini review.

Authors:  G Cizza; R J Brown; K I Rother
Journal:  J Endocrinol Invest       Date:  2012-05-08       Impact factor: 4.256

Review 8.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

9.  Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer.

Authors:  Andreana N Holowatyj; Richard Viskochil; Dominik Ose; Benjamin Tingey; Benjamin Haaland; Dalton Wilson; Mikaela Larson; Sara Feltz; Mark A Lewis; Howard Colman; Cornelia M Ulrich
Journal:  J Adolesc Young Adult Oncol       Date:  2020-07-29       Impact factor: 2.223

10.  Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial.

Authors:  Gregory G Schwartz; Stephen J Nicholls; Peter P Toth; Michael Sweeney; Christopher Halliday; Jan O Johansson; Norman C W Wong; Ewelina Kulikowski; Kamyar Kalantar-Zadeh; Henry N Ginsberg; Kausik K Ray
Journal:  Cardiovasc Diabetol       Date:  2021-06-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.